Parallax Volatility Advisers
BLUE

Parallax Volatility Advisers’s bluebird bio BLUE Stock Holding History

Parallax Volatility Advisers’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,245
Closed -$648K – 2883
2021
Q4 		$648K Sell
3,245
-1,711
-35% -$404K ﹤0.01% 2071
2021
Q3 		$1.23M Sell
4,956
-1,436
-22% -$411K ﹤0.01% 1893
2021
Q2 		$2.65M Buy
+6,392
New +$2.53M ﹤0.01% 1522

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Parallax Volatility Advisers's BLUE Position: Q3 2019 in Review

Parallax Volatility Advisers sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 12 shares — an estimated $20K sold.

Parallax Volatility Advisers first reported a position in BLUE in Q4 2017 and held it in 7 quarters. The position peaked at $1.33M in Q4 2017. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.

  • Parallax Volatility Advisers reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 12 bluebird bio shares in Q3 2019, an estimated $20K.
  • Parallax Volatility Advisers first reported a position in bluebird bio in Q4 2017 and held it in 7 quarters.
  • Parallax Volatility Advisers's bluebird bio position peaked at $1.33M in Q4 2017.
  • 241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.

Based on Parallax Volatility Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.